 |
市場調查報告書
商品編碼
1146201
脊柱成像市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）Spinal Imaging Market - Growth, Trends, And Forecasts (2022 - 2027) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
脊柱成像市場預計在預測期間（2022-2027 年）以近 5.2% 的複合年增長率增長。
COVID-19 大流行影響了 2020 年脊柱成像市場的需求。在大流行初期，封鎖限制、非緊急預約和住院治療的暫停以及嚴格的社交距離規則減少了對脊柱影像診斷的需求。例如，2021 年 10 月發表在 Frontier in Neurology 上的研究“SARS-CoV-2 感染過程中神經系統並發症的放射學表現”的研究結果表明，診斷中最重要的一點是使用放射學技術，以確定與 SARS-CoV-2 感染相關的神經系統症狀的原因。使用放射成像技術跟蹤各種症狀的出現對於確定其嚴重程度和程度至關重要，尤其是在存在神經系統病變時。因此，雖然在 COVID-19 期間對脊髓成像的需求有所增加，但患者對成像中心的訪問量減少可能會阻礙市場增長。
推動市場增長的特定因素包括全球脊柱疾病負擔的增加以及椎間盤突出症、椎管狹窄症、馬尾神經綜合徵和神經根病等脊柱疾病患病率的上升，預計將推動市場增長。此外，增加患者獲得醫學影像服務的機會和增加脊柱外科手術量預計將進一步推動市場增長。此外，根據發表在 2021 年 3 月的《科學報告》上的“使用醫療保險數據按類型、年齡、性別和肥胖進行脊柱退行性疾病診斷的患病率”研究，年齡是診斷出脊柱退行性疾病患病率的一個因素。比率為 27.3總體百分比。此外，美國國家生物技術信息中心於 2021 年發表的一篇題為“脊髓損傷”的論文指出，美國每年約有 17,000 例新的脊髓損傷 (SCI) 發生。因此，脊柱退行性變和脊髓損傷患病率的增加有望推動市場增長。
此外，各種私營和公共部門組織對脊髓損傷和疾病治療的資助預計將推動市場增長。例如，2022 年 1 月，來自 UBC 的研究人員領導了一筆 2400 萬美元的贈款，用於治療脊髓損傷。這些舉措支持市場擴張。此外，市場參與者頻繁推出新產品，並在各自細分市場採取不同的增長策略，有望推動市場增長。例如，2021 年 9 月，Konica Minolta Healthcare Americas, Inc. 宣布，能夠在患者進行全方位運動時對頸椎（C-spine）和腰椎（L-spine）的生理運動進行成像。 enable dynamic 報導稱，數字射線照相術 (DDR) 正在美國脊柱中心迅速獲得認可。
因此，上述所有因素預計將在預測期內推動市場增長。然而，與成像方式相關的高成本正在抑制市場增長。
主要市場趨勢
預計 MRI 細分市場將在預測期內主導市場
在脊髓成像市場中，MRI 部分佔據了最大的市場份額。 MRI 具有高軟組織對比度、出色的空間分辨率和多方面的成像能力，可用於檢查脊髓。先進的 MRI 掃描儀具有高磁強度 (3.0T) 和低信噪比 (SNR)，可縮短掃描時間並提高患者的依從性和依從性。根據題為磁共振成像在急性脊髓損傷中的非正式決策中的作用的研究： 2021年11月臨床醫學雜誌《A Systematic Review and Meta-Analysis》，在脊柱外傷的初步評估中，影像學是至關重要的。然而，脊髓損傷的特異性是100%。因此，MRI在檢測脊髓中的有效性預計損傷將推動對 MRI 系統的需求，從而促進細分市場的增長。
主要市場參與者對尖端產品的開拓和產品技術進步預計將推動該細分市場的增長。例如，2022 年 1 月，雅培披露美國食品藥品監督管理局 (FDA) 批准 Proclaim XR 脊髓刺激 (SCS) 系統與 Octrode Read Did 的新增強型磁共振成像 (MRI) 兼容性。在擴展的 MRI 標籤下，佩戴 Proclaim XR SCS 設備的患者可以受益於更高質量的圖像和更快的 MRI 掃描時間。
MRI 圖像軟件開發的進步將有助於增加對 MRI 圖像的需求。 2021 年 5 月，印度放射學公司 Synapsica 與 Aarthi Scans and Labs 合作，推出了名為“Spindle”的人工智能 (AI) 助手，為診斷鍊提供脊柱磁共振成像 (MRI) 增加。 Spindle 在脊柱的 MRI 掃描中自動報告超過 35 種退行性或與年齡相關的情況。這將使放射科醫生花費在脊柱 MRI 檢查上的時間減少約 70%，從而可以快速識別和報告變化和病理，以診斷疾病並量化退化程度。
因此，上述所有因素預計將在預測期內促進該細分市場的增長。
預計北美在預測期內將佔據較大的市場份額
北美占主要市場份額，預計在預測期內將保持其主導地位，原因是對該產品的高需求以及腰椎間盤切除術和腰椎融合術等椎體手術病例數量的增加。它主要用於通過大投資支持的研發來推動醫療保健技術的進步，以及用於診斷脊髓和神經的壓迫和炎症、椎骨、椎間盤和脊髓的感染，以及內部和周圍的腫瘤脊髓。據信這是由於使用的 X 射線和 CT 設備的數量增加所致。
美國國家生物技術信息中心 2021 年發表的一篇題為“脊髓損傷”的文章指出，美國每年約有 17,000 例新的脊髓損傷 (SCI) 病例。此外，根據美國神經外科學會 2021 年 6 月發布的數據，美國有超過 45 萬人被證實患有脊髓損傷 (SCI)。此外，根據 2021 年 3 月美國國家生物技術信息中心的論文《使用醫療保險數據按類型、年齡、性別和肥胖進行的脊柱退行性疾病診斷的患病率》，診斷出脊柱退行性疾病的患病率為 27.3%。因此，脊髓疾病患病率的增加預計將在預測期內推動市場增長。
此外，公司越來越注重採用各種業務策略，例如產品批准、發布、併購、合作夥伴關係等，以保持其市場地位，這也有助於市場的增長。 2020 年 11 月，西門子 Healthineers 在北美放射學會 (RSNA) 年會上推出了 LUMINOUS Lotus Max。它是一種二合一遠程控製成像系統，可無縫集成透視和射線照相，以提高生產力並優化臨床操作。他還為全脊柱檢查和基本干預做出了貢獻。 2020 年 8 月，Wenzel Spine Inc. 宣布收購 Statera Spine，這是一家脊柱成像分析公司，致力於推進對急性和慢性脊柱疾病患者的護理。此外，2020 年 2 月，Alphatec Holdings Co., Ltd. 收購了 EOSimaging, SA。此次收購將把脊柱成像和解剖模型整合到平台中，為手術體驗提供資訊。預計這種區域進步將促進北美地區的市場增長。
競爭格局
脊柱成像市場競爭適度，有許多大型企業進入市場。最近，專注於引進新技術的中小企業有所增加。布魯克、佳能醫療系統、富士醫療系統和 GE Healthcare 等公司在脊柱成像市場佔有相當大的份額。主要公司是 Koninklijke Philips N.V、Siemens Healthineers、Meiso Ltd 和 Hitachi Ltd。
其他特典
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第 1 章介紹
- 調查假設和市場定義
- 調查範圍
第 2 章研究方法
第 3 章執行摘要
第 4 章市場動態
- 市場概覽
- 市場促進因素
- 脊柱疾病的發病率增加
- 來自私營和公共部門的資金增加
- 技術進步
- 市場抑制因素
- 與成像方式相關的高成本
- 波特五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分（基於價值的市場規模：百萬美元）
- 按產品類型
- X 射線
- CT 掃描
- 核磁共振
- 超聲波
- 按應用
- 脊髓感染
- 椎體骨折
- 脊柱癌
- 脊髓/神經壓迫
- 按最終用戶
- 醫院
- 影像診斷中心
- 門診中心
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 英國
- 德國
- 法國
- 意大利
- 西班牙
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東和非洲
- 海合會
- 南非
- 其他中東
- 南美洲地區
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第 6 章競爭格局
- 公司簡介
- Canon Medical Systems
- Bruker
- Mediso Ltd.
- GE Healthcare
- Shimadzu Corp.
- Koninklijke Philips NV
- Fujifilm Corporation（Hitachi, Ltd）
- Siemens Healthineers
第 7 章市場機會和未來趨勢
The spinal imaging market is expected to register a CAGR of nearly 5.2% over the forecast period (2022-2027).
The COVID-19 pandemic affected the demand for the spinal imaging market in 2020. During the early pandemic, the demand for spinal imaging had reduced due to the lockdown restrictions, suspension of non-urgent scheduled visits and hospitalizations, and stringent social distancing norms. For instance, the research study "Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection" was Published in Frontier in Neurology in October 2021, one of the most crucial aspects of diagnosis is using radiological techniques to determine the cause of neurological symptoms linked to SARS-CoV-2 infection. Utilizing radiological imaging techniques to track the emergence of different symptoms is essential to determine the severity and extent of involvement, especially when there is nervous system involvement. Thus, the demand for spinal imaging has increased during COVID-19, however, declined patient visits to the imaging center may hamper the market growth.
Certain factors driving the market growth include the rising global burden of spinal disorders and the rising prevalence of spinal disorders, such as herniated disc, spinal stenosis, cauda equina syndrome, and radiculopathy, expected to drive the growth of the market. Developing patients' accessibility to medical imaging services and the growing procedural volume of spinal surgeries are further expected to boost the market growth. Moreover, according to the study "Prevalence of Spine Degeneration Diagnosis by Type, Age, Gender, and Obesity Using Medicare Data" published in the Scientific Report in March 2021, Age was a factor in the prevalence of diagnosed spinal degenerative disease, which was 27.3 percent overall. Additionally, according to an article published by the National Center for Biotechnology Information, in 2021, titled "Spinal Cord Injuries", stated that in the United States, there are approximately 17,000 new cases of spinal cord injuries (SCI) each year. Thus, the increasing prevalence of spinal degeneration and spinal cord injury is anticipated to boost the market growth.
Moreover, rising in the funding for the treatment of the spinal cord injury and diseases treatment from the various private and public sector organization is expected to accelerate the market growth. For instance, In January 2022, Researchers from UBC have taken the lead on a USD 24 million grant for the treatment of spinal cord injuries. Such initiatives supports the market expansion. Furthermore, market players are frequently launching new products and adopting various growth strategies in their respective segments, which is likely to drive market growth. For Instance, in September 2021, Konica Minolta Healthcare Americas, Inc. reported that Dynamic Digital Radiography (DDR) rapidly gaining acceptance in spine centers across the United States due to its ability to capture the physiological motion of the cervical spine (C-spine) and lumbar spine (L-spine) as a patient moves through the full range of motion.
Thus, all aforementioned factors is expected to drive the growth of the market over the forecast period. However, high cost associated with the imaging modality restraint the market growth.
Key Market Trends
MRI Segment is Expected to Dominate the Market Over the Forecast Period
The MRI segment held the largest market share in the spinal imaging market. MRI offers high soft-tissue contrast, excellent spatial resolution, and multiplanar imaging capabilities, which helps in spinal investigations. Advanced MRI scanners have elevated magnetic strength (3.0T) and less signal-to-noise ratio (SNR), decreasing imaging time and improving patient compliance and installation rate. According to the study titled "The Role of Magnetic Resonance Imaging to Inform Clinical Decision-Making in Acute Spinal Cord Injury: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine in November 2021, In the initial assessment of spinal trauma, imaging is crucial. MRI had a 40% sensitivity for fracture detection but 100% specificity for spinal cord injury. Thus, the effectiveness of the MRI in the detection of spinal cord injury is expected to drive the demand for MRI systems thereby boosting the segment growth.
The development of cutting-edge products by major market players and technological advancements in products are expected to boost the segment growth. For Instance, in January 2022, Abbott revealed that the United States Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode leads. Under the expanded MRI labeling, patients with a Proclaim XR SCS device can benefit from higher quality images with faster MRI scan times.
The advancement in software development for MRI images helps boost the demand for MRI imaging. In May 2021, Indian Radiology company Synapsica partnered with Aarthi Scans and Labs to deploy its artificial intelligence (AI) assistant named 'Spindle' to offer spine magnetic resonance imaging (MRIs) for the diagnostic chain. Spindle automatically reports over 35 degenerative or age-related pathologies in MRI scans of the spine. This helps reduce the time spent by radiologists on spine MRIs by almost 70% and quickly identify and report variations and pathologies to diagnose the disease and quantify the degree of degeneration.
Thus, all aforementioned factors expected to boost the segment growth over the forecast period.
North America is Expected to Have the Significant Market Share over the Forecast Period
North America holds the major market share and is expected to continue its dominance over the forecast period due to high product demand and rising cases of vertebral surgeries like lumbar discectomy and lumbar fusion. This is attributed primarily to the advancements in healthcare technologies, credited to extensive investment-backed R&D, and the availability of a rising number of X-ray and CT devices which are used to diagnose any compressions or inflammation of the spinal cord and nerves, infection of the vertebrae, discs, spinal cord or tumors in the spinal cord or surrounding areas.
According to an article published by the National Center for Biotechnology Information, in 2021, titled "Spinal Cord Injuries", stated that in the United States, there are approximately 17,000 new cases of spinal cord injuries (SCI) each year. Moreover, According to the data published by the American Association of Neurological Surgeons, in the June 2021 report, it has been observed that more than 450,000 people in the United States are living with a spinal cord injury (SCI). Additionally, According to an article published by the National Center for Biotechnology Information, in March 2021, titled "Prevalence of Spine Degeneration Diagnosis by Type, Age, Gender, and Obesity Using Medicare Data," the prevalence rate of diagnosed spinal degenerative disease was found to be 27.3%. Thus, growing the prevalence of the spinal cord disaeses is expected to drive the growth of the market over the forecast period.
Moreover, with the increasing focus of the companies on adopting various business strategies such as product approvals, launches, mergers and acquisitions, and partnerships, withholding their market position is also contributing to the market growth. In November 2020, Siemens Healthineers introduced the LUMINOUS Lotus Max at the Annual Meeting of the Radiological Society of North America (RSNA). It is a 2-in-1 remote-controlled imaging system that seamlessly integrates fluoroscopy and radiography for increased productivity and optimized clinical operations. It also helped in full-spine examinations and basic interventions. In August 2020, Wenzel Spine Inc. announced the acquisition of Statera Spine, a spine imaging analytics company that facilitates treatment for patients with acute and chronic spine issues. Additionally, in February 2020, Alphatec Holdings, Inc. acquired EOS imaging, SA. This transaction will integrate spine imaging and anatomical modeling onto the platform to inform the operative experience.Such regional advancement is expected to boost the market growth in the North American region.
Competitive Landscape
The spinal imaging market is moderately competitive and consists of many major players. Recently, mid-size to smaller companies have emerged, focusing on introducing new technologies. Companies like Bruker, Canon Medical Systems Corp., Fujifilm Medical Systems, and GE Healthcare hold a substantial market share in the spinal imaging market. The key players are Koninklijke Philips N.V, Siemens Healthineers, Mediso Ltd, and Hitachi Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rise in the incidences of spinal disorders
- 4.2.2 Rise in the funds by private and public sector
- 4.2.3 Technological advancements.
- 4.3 Market Restraints
- 4.3.1 High cost associated with imaging modalities
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Product Type
- 5.1.1 X-ray
- 5.1.2 CT scan
- 5.1.3 MRI
- 5.1.4 Ultrasound
- 5.2 By Application
- 5.2.1 Spinal Infection
- 5.2.2 Vertebral Fractures
- 5.2.3 Spinal Cancer
- 5.2.4 Spinal Cord and Nerve Compression
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Diagnostic Imaging Center
- 5.3.3 Ambulatory Care Center
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 United kingdom
- 5.4.2.2 Germany
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 India
- 5.4.3.3 Japan
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Canon Medical Systems
- 6.1.2 Bruker
- 6.1.3 Mediso Ltd.
- 6.1.4 GE Healthcare
- 6.1.5 Shimadzu Corp.
- 6.1.6 Koninklijke Philips NV
- 6.1.7 Fujifilm Corporation (Hitachi, Ltd)
- 6.1.8 Siemens Healthineers
